Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anni Christensen

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|May 22, 2003
Vitronectin in human breast carcinomasMads Aaboe, Birgitte V Offersen, Anni Christensen, et al.
Journal of Cellular Biochemistry|September 18, 2023
Analysis of cortical cell polarity by imaging flow cytometryJesper H Jespersen, Andras Harazin, Anja B Bohn, et al.
Proteins|January 11, 2018
Crystal structure of tetrameric human Rabin8 GEF domainMelanie Vetter, Niels Boegholm, Anni Christensen, et al.
The Journal of Biological Chemistry|July 29, 2008
Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domainChristine R Schar, Jan K Jensen, Anni Christensen, et al.
Biochemistry|August 27, 2009
Nonproteolytic induction of catalytic activity into the single-chain form of urokinase-type plasminogen activator by dipeptidesKenneth A Bøtkjaer, Aleksandra A Byszuk, Lisbeth M Andersen, et al.
The Biochemical Journal|March 27, 2003
Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligandsKatrine E Pedersen, Anja P Einholm, Anni Christensen, et al.
The Journal of Biological Chemistry|January 29, 2025
Integrative in silico and biochemical analyses demonstrate direct Arl3-mediated ODA16 release from the intraflagellar transport machineryJiaolong Wang, Rune T Kidmose, Niels Boegholm, et al.
Thrombosis and Haemostasis|July 31, 2003
Biochemical importance of glycosylation of plasminogen activator inhibitor-1Ann Gils, Katrine E Pedersen, Peter Skottrup, et al.
The Journal of Biological Chemistry|September 6, 2005
A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibitionMartin Hansen, Troels Wind, Grant E Blouse, et al.
The FEBS Journal|October 18, 2006
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesisSune Skeldal, Jakob V Larsen, Katrine E Pedersen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|May 22, 2003
Vitronectin in human breast carcinomasMads Aaboe, Birgitte V Offersen, Anni Christensen, et al.
Journal of Cellular Biochemistry|September 18, 2023
Analysis of cortical cell polarity by imaging flow cytometryJesper H Jespersen, Andras Harazin, Anja B Bohn, et al.
Proteins|January 11, 2018
Crystal structure of tetrameric human Rabin8 GEF domainMelanie Vetter, Niels Boegholm, Anni Christensen, et al.
The Journal of Biological Chemistry|July 29, 2008
Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domainChristine R Schar, Jan K Jensen, Anni Christensen, et al.
Biochemistry|August 27, 2009
Nonproteolytic induction of catalytic activity into the single-chain form of urokinase-type plasminogen activator by dipeptidesKenneth A Bøtkjaer, Aleksandra A Byszuk, Lisbeth M Andersen, et al.
The Biochemical Journal|March 27, 2003
Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligandsKatrine E Pedersen, Anja P Einholm, Anni Christensen, et al.
The Journal of Biological Chemistry|January 29, 2025
Integrative in silico and biochemical analyses demonstrate direct Arl3-mediated ODA16 release from the intraflagellar transport machineryJiaolong Wang, Rune T Kidmose, Niels Boegholm, et al.
Thrombosis and Haemostasis|July 31, 2003
Biochemical importance of glycosylation of plasminogen activator inhibitor-1Ann Gils, Katrine E Pedersen, Peter Skottrup, et al.
The Journal of Biological Chemistry|September 6, 2005
A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibitionMartin Hansen, Troels Wind, Grant E Blouse, et al.
The FEBS Journal|October 18, 2006
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesisSune Skeldal, Jakob V Larsen, Katrine E Pedersen, et al.
Pageof 3